Sun Life’s Strategic Pivot: U.S. Medicaid Dental Gets Smaller as Asia and Stop-Loss Carry the Quarter
Sun Life Financial reported another strong quarter — underlying EPS up 13%, ROE at 19.1%, and record results in Canada — but the conversation on the call was less about the beat and more about a deliberate strategic shift. The company is openly shrinking its U.S. Medicaid dental business, refocusing on commercial and stop-loss growth, while Asia and asset management increasingly carry the earnings story.
The Dental Drag and a Deliberate De-emphasis
The most striking commentary came from CEO Kevin Strain, who made clear that the state-funded dental book is no longer a priority.
That is a stark admission for a business the company acquired for scale in 2022. The pivot is already visible: Medicaid membership is down 9% year-over-year, and the company is walking away from unprofitable contracts. This is not a one-quarter decision. David Healy, President of Sun Life U.S., told analysts that the actions taken to date "are unlikely to fully offset the Medicaid volume-related pressures we're seeing over the near term," and that membership would remain lower for the rest of the year. The Dental side is being repositioned toward a more profitable mix, but the state business will be a drag for at least a year.I watch David and his team. They're fixing the fundamentals of the state business. It is going to be a fundamentally smaller part of what we do on the dental side, building out the commercial.
Meanwhile, the stop-loss business — another U.S. growth engine — continues to perform, but with a seasonality nuance that analysts struggled to reconcile. Healy explained that the "unfavorable but expected" morbidity line was simply the build-up of IBNR reserves. “The Q2 results do include known seasonality from the buildup of IBNR reserves. That is what is in that unfavorable morbidity line. You could consider it unfavorable but expected.” — Gabriel Dechaine, Analyst or Investor · 2026-08-07 The market is watching this closely because the 1/1/26 cohort is only 15% complete, and the 1/1/25 cohort is 97% complete and in line with expectations. The company is confident in its pricing discipline, and the hard market is driving 86% sales growth in stop-loss this quarter. But the employee benefits business, which had a record Q2 last year, reverted to more normal trends, masking some of the stop-loss lift.
Asia and Canada: The Growth Engines
If the U.S. is being reshaped, Asia is clearly accelerating. Sales in the region are up 20%, with Hong Kong up 20% and Indonesia up 69%. The CSM margin is easing from peak levels — new business CSM fell year-over-year in Asia — but Manjit Singh framed it as a return to a more sustainable competitive equilibrium. On the call, he noted: "The MCV is really only about 10% of that business" when asked about high-net-worth exposure to China, signaling that the franchise is diversified beyond the Mainland visitor segment. That matters as the company leans on Asia for future earnings growth.
In Canada, the story is about the durability of favorable insurance experience. Jessica Tan, who leads the Canadian insurance business, doubled down on the sustainability of those gains: “If you look at the past 8 quarters, we have had a positive insurance experience, on average about CAD 57 million every quarter pre-tax.” — Jessica Tan, Executive (likely in charge of Canadian insurance experience or actuarial) · 2026-08-07 She attributed the consistency to investments in people, processes, and digital tools, not just luck. Canada delivered record Q2 earnings, and wealth AUM hit CAD 286 billion, up 18%.
Asset Management: The Unified Platform
Sun Life’s asset management platform is showing early signs of the "flywheel" the company has been building. The Private Credit business closed the largest direct lending fund in its history at $10.8 billion, and the company is now operating SLC as a unified platform. Steve Peacher, who runs SLC, told analysts the margin story is now about scale and expense efficiency: "We fully expect that margin should expand significantly." The company is also investing in AI as a differentiator — a founding member of an AI consortium with Scotiabank and Telus, and launching an agentic AI platform internally. These are exactly the kind of enterprise-level initiatives that give the company a technology edge in a sector that is traditionally slow to innovate.
The quarter also saw a continuation of the company’s disciplined capital framework. Holding-company cash stands at CAD 2.3 billion, LICAT remains at a strong 145%, and the newly renewed NCIB is buying shares. The broad based growth across geographies and business lines is what underpins the medium-term targets, but the dental pivot is the single most important strategic signal for investors.